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Abstract
Background: Quantification of bioactive, free serum
cortisol concentrations can characterize adrenocorti-
cal function more appropriately compared to total
serum cortisol measurement. Ultrafiltration or equi-
librium dialysis of serum samples allow direct meas-
urement of free serum cortisol concentrations but
respective methods have poorly been validated so far.
The aim of our study was to investigate the analytical
performance of free serum cortisol measurement
employing equilibrium dialysis and ultrafiltration.
Methods: Two commercially available ultrafiltration
devices and self-assembled dialysis cells, respective-
ly, were studied. Cortisol was quantified in filtrate or
dialysate using an automated immunoassay system.
Using two serum pools, the inter-assay coefficient of
variation was determined for the three methods and
a method comparison was performed.
Results: Inter-assay coefficients of variation (ns10)
between 3.2% and 14.8% were observed in the impre-
cision study. Method comparison demonstrated close
agreement between free serum cortisol results
obtained by ultrafiltration and equilibrium dialysis,
respectively (equilibrium dialysiss1.2=ultrafiltra-
tionq3.9 nmol/L; rs0.99; ns35).
Conclusions: Direct quantification of free serum cor-
tisol after equilibrium dialysis or ultrafiltration of the
samples offers acceptable reproducibility and results
in close agreement can be obtained. Both methods
can potentially be introduced into a routine laboratory
setting.
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Introduction
Measurement of total serum concentrations of thyroid
and steroid hormones is of limited biological validity,
because the bioavailability of these hormones is sub-
stantially determined by variable concentrations and
binding characteristics of the respective hormone
binding proteins. This problem has been addressed
for thyroid function testing by the introduction of
direct measuring free hormone assays applicable to
unprocessed serum samples. In the diagnostic work-
up of patients with suspected Cushing’s or Addison’s
disease in an outpatient setting, quantification of sal-
ivary cortisol may avoid the bias of total serum cor-
tisol measurement caused by variable concentrations
of the corticosteroid-binding globulin (CBG) (1).
Besides typical endocrine diseases, reliable analytical
methods are needed to disclose adrenocortical dys-
function in critical illness (2–5), a condition which is
typically associated with substantial and variable
depletion of CBG and albumin (3, 5–10). Determina-
tion of salivary cortisol concentrations may be con-
founded due to reduced flow of saliva in critically ill
patients (11); consequently, there is substantial inter-
est in accurate methods to determine the serum con-
centration of free cortisol concentrations in critical
care medicine. Indeed superior diagnostic perform-
ance of free serum cortisol determination in critically
ill patients has been suggested in previous reports (5,
12, 13).
Based on the binding characteristics of CBG, a cal-
culation of free serum cortisol concentrations can be
performed from the concentrations of total serum cor-
tisol, CBG, and albumin, respectively (12, 14). This
approach has been used in a number of investiga-
tions, but important limitations have to be recognized:
besides the immunoreactive concentration of CBG,
individual variations in the tertiary structure of CBG
can determine cortisol binding (15, 16). Furthermore,
no automated test for CBG measurement is available,
and calculated free serum cortisol incorporates the
inaccuracy of two immunometric assays. As a poten-
tially more accurate approach, direct quantification of
free serum cortisol after equilibrium dialysis of serum
samples may be applied (5, 17, 18). As applies for
equilibrium dialysis, a protein-free fraction can also
be obtained from serum samples by ultrafiltration
techniques (14, 19).
So far, few data have been reported on the analy-
tical reproducibility of free serum cortisol measure-
ment using equilibrium dialysis or ultrafiltration, and
on the agreement between these analytical approach-
es. Therefore, the aim of the present work was to per-
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Figure 1 Sartorius ultrafiltration device, Millipore ultrafiltra-
tion device, and equilibrium dialysis cell, each loaded with
1 mL of serum.
form a comparative validation of these techniques,
with quantification of cortisol in dialysate or filtrate
using a modern fully automated immunoanalyzer
system.
Materials and methods
Equilibrium dialysis of serum samples was essentially per-
formed as described previously (17, 18, 20). For conditioning
of dialysis membranes, an approx. 20-cm long piece of a dry
membrane tube (Carl Roth GmbH, Karlsruhe, Germany,
regenerated cellulose, molecular weight cut off 4000–6000,
25 mm wall thickness) was placed into 1.5 L of deionized
water heated to 508C; after 30 min of gentle stirring, the
water was exchanged by fresh deionized water of room tem-
perature; again after a further 30 min the water was
exchanged. In this water, the membrane can be kept for sev-
eral weeks at q48C. Dialysis cells were assembled from
1.5 mL polypropylene reaction vials. The lid of a vial was cut
and filled with Roche Cobas Elecsys Universal Diluent
(approx. 250 mL) (Roche Diagnostics, Mannheim, Germany),
here serving as the dialysis buffer. A piece of the precondi-
tioned dialysis membrane was laid upon the filled lid and
the body of the vial was placed upside-down onto the cov-
ered lid, thereby fixing the membrane. The bottom of the vial
was cut away and 1 mL of serum was filled into the cell
which was subsequently closed with a laboratory film. These
dialysis cells were kept at 378C overnight (16–18 h). After
disassembling of the cells, the dialysate was harvested out
of the lid with a pipette tip.
A specially designed dialysis cell device is commercially
available and offers easier handling compared to the
described self-assembled dialysis cells (Micro-Equilibrium
DialyzerTM; Harvard Apparatus, Holliston, MA, USA;
www.harvardapparatus.com). In this cell, however, a volume
ratio between sample and dialysis buffer of 1:1 is fixed, in
contrast to a ratio of 4:1 with the self-assembled cells. It can
be reasonably assumed that, the higher the sample-to-dia-
lysate volume ratio is, the less the actual binding conditions
between cortisol and proteins are disturbed in dialysis cells
compared to the physiological condition in blood. Further-
more, we found poor reproducibility of the Micro-Equilibri-
um DialyzerTM for free serum cortisol measurement in initial
trials, and therefore decided not to further study this com-
mercial dialysis cell.
Two different ultrafiltration devices were investigated in
our study: Centrisart I (Sartorius AG, Goettingen, Germany,
cut-off 10,000; www.sartorius.com); and Centrifree YM-30
(cut-off 30,000, Millipore Corporation, Billerica, USA;
www.millipore.com). These devices are centrifuged to
achieve filtration of the loaded serum samples through a
membrane by centrifugal force. In order to remove preser-
vatives from the filtration membranes before use, the
devices were loaded with 1 mL of deionized water, which
was discarded after centrifugation. Subsequently, 1 mL of
serum was filled into the filtration devices which were then
kept at 378C for 30 min to achieve equilibrium of protein
binding. The ultrafiltration devices were then centrifuged at
2100 g for 7 min (Centrisart) or 25 min (Centrefree) at a tem-
perature setting of 378C. A thermostated Hettich Rotanta RP
(Hettich, Tuttlingen, Germany) benchtop centrifuge was
used. The temperature within the centrifuge chamber was
recorded by an electronic device; typically, variationbetween
35–408C was observed during a centrifugation run. Signifi-
cant between-sample variation of ultrafiltrate volumes
obtained from 1 mL of sample was observed in initial trials
for both devices tested; the duration of the centri-
fugation was optimized for either system in order to obtain
at least 200 mL of ultrafiltrate in the majority of samples
processed, however, ultrafiltrate volumes between 200 mL
and 400 mL were typically observed.
Ultrafiltration devices and a dialysis cell are shown in Fig-
ure 1.
Ultrafiltrate and dialysate samples, respectively, were all
assayed for cortisol concentrations using the Roche Cobas
Cortisol assay implemented on a Roche Elecsys 2010 immu-
noanalyzer system (Roche Diagnostics, Mannheim, Ger-
many).
To study the imprecision of the methods, two serum pools
were prepared from residual clinical samples; pool 1 was
prepared from serum of intensive care patients; pool 2
from serum of outpatients. Aliquots of these pools were
stored at y208C and were analyzed in each ten indep-
endent analytical runs over a 6-week period. Total serum
cortisol1) was 723 nmol/L in pool 1 and 439 nmol/L in pool
2; CBG was 36.9 mg/mL in pool 1 and 68.1 mg/mL in pool 2;
albumin was 21 g/L in pool 1 and 43 g/L in pool 2.
Since the Centrifree devices offered superior reproducibil-
ity compared to the Centrisart devices (see Results section),
only the Centrifree devices were used for a subsequent
method comparison study. For this study, 30 residual serum
samples were used (9 outpatients; 21 intensive care unit
patients not receiving exogenous steroids), and an additional
five pool samples. Total serum cortisol concentrations were
determined using the Roche Cobas cortisol assay and the
concentrations of the CBG were determined with a radio-
immunoassay (Asbach Medical Products, Obrigheim, Ger-
many); C-reactive protein (CRP) was quantified with a
latex-enhanced immuno-turbidimetric assay, albumin with
the bromocresol green photometric color test.
A calculation of individual free serum cortisol concentra-
tion from total cortisol and CBG concentrations was per-
formed as described by Coolens et al. (14), corrected for
serum albumin concentrations according to Ho et al. (12).
Conversion of units: Cortisol: wnmol/Lx = 0.0362™ wmg/dLx1)
wmg/dLx = 27.6™ wnmol/Lx
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Table 1 Inter-assay imprecision (ns10) of three methods for the quantification of free serum cortisol concentrations.
Pool 1 Pool 2
Equilibrium Ultrafiltration, Ultrafiltration, Equilibrium Ultrafiltration, Ultrafiltration,
dialysis Sartorius Millipore dialysis Sartorius Millipore
device device device device
Mean free cortisol 183 nmol/L 124 nmol/L 181 nmol/L 17.7 nmol/L 11.9 nmol/L 17.4 nmol/L
concentration
% Free cortisol 25.3% 17.1% 25.0% 4.0% 2.7% 4.0%
Coefficient of 7.3% 8.3% 3.2% 14.8% 10.0% 6.9%
variation
Total serum cortisol concentrations and free serum corti-
sol results obtained from the three analytical approaches
were compared according to Passing and Bablok (21) with
calculation of Pearson’s r.
Results and discussion
Best reproducibility was observed for the Centrifree
ultrafiltration device with inter-assay coefficients of
variation clearly below 10% for both pools (Table 1).
The reproducibility of the equilibrium dialysis method
was found inferior but still acceptable with an inter-
assay coefficient of variation of approx. 15% for pool
2.
In a previous article, Lentjes et al. (19) have report-
ed an important impact of temperature variations
within the centrifuge on free serum cortisol results by
ultrafiltration, requiring specially manufactured and
not commercially available laboratory equipment. We
observed, in contrast, acceptable reproducibility also
using a standard centrifuge with relatively poor tem-
perature control. Conversely, in our experience,
washing of the filtration devices with distilled water
(as described above) is essential for reproducible
results.
Concentrations of total cortisol, CBG, albumin and
the CRP, respectively, were as follows in 35 samples
used for method comparison:
Total serum cortisol wnmol/Lx: mean 558 (SD 367);
median 461; interquartile range (IQR) 337–762; range
71.8–1634. CBG wmg/mLx: mean 39.6 (SD 17.7); medi-
an 34.9; IQR 23.9–50.3; range 16.1–80.7. Albumin
wg/Lx: mean 32 (SD 12); median 26; IQR 22–44; range
14–50; CRP wmg/Lx: mean 86 (SD 87); median 37; IQR
6.0–154; range -5.0–266.
Poor nominal correlation was found between total
serum cortisol concentrations and free serum cortisol
results; this applied for calculated free cortisol
(rs0.87), for measured free cortisol after ultrafiltra-
tion (rs0.75), and measured free cortisol after equi-
librium dialysis (rs0.76) (Figure 2A–C). These plots
highlight the non-linear binding characteristics
between cortisol and CBG as predicted by the results
from Coolens et al. (14).
Excellent correlation was observed between free
serum cortisol results obtained by equilibrium dialy-
sis (ED) and ultrafiltration (UF), respectively (Figure 3);
however, slightly higher results were found with the
dialysis method:
EDs1.2=UFq3.9 nmol/L
(95% CI for slope, 1.10–1.20; 95% CI for intercept,
2.8–5.5 nmol/L; rs0.99).
The close agreement between free serum cortisol
measured after equilibrium dialysis and ultrafiltration,
respectively, found in our investigation is in accor-
dance with the data reported by Ho et al. (12).
Substantially higher free serum cortisol concentra-
tions were found by the directly measuring methods
compared to calculated free serum cortisol (CALC) for
the entire set of 35 samples studied:
EDs2.0=CALC–10.8 nmol/L
(95% CI for slope, 1.56–2.41; 95% CI for intercept,
y30.4–1.1 nmol/L; rs0.96) (Figure 4A)
UFs1.7=CALC–11.9 nmol/L
(95% CI for slope, 1.30–2.21; 95% CI for intercept,
y33.1–y2.5 nmol/L; rs0.96) (Figure 4B).
ED wnmol/Lx: mean 160 (SD 273); median 80.0; IQR
16.6–149; range 3.0–1333
UF wnmol/Lx: mean 135 (SD 237); median 63.5; IQR
16.6–119; range 2.8–1148
CALC wnmol/Lx: mean 77.3 (SD 102); median 38.6; IQR
19.3–77.3; range 3.6–433
Interestingly, in the subset of samples with CRP
concentrations below 5.0 mg/L (ns9; albumin con-
centrations ranging from 39 to 46 g/L) closer agree-
ment was found between calculated and measured
free serum cortisol concentrations compared to the
entire set of samples studied wfor CRP -5.0 mg/L,
mean free serum cortisol results: ED 16.6 nmol/L (SD
8.3); UF 11.0 nmol/L (SD 6.1); CALC, 19.3 nmol/L (SD
11.0)x.
The mean percentage of free cortisol from total cor-
tisol was 3.7% and 6.0% in samples with CRP con-
centrations below 5.0 mg/L, as determined with
ultrafiltration and equilibrium dialysis, respectively; a
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Figure 2 Total and free serum cortisol results found in 35
clinical samples.
(A) free serum cortisol calculated from total serum cortisol
and CBG concentrations (12); (B) free serum cortisol found
using ultrafiltration; (C) free serum cortisol found using equi-
librium dialysis).
Figure 3 Free serum cortisol concentration measured after
ultrafiltration and equilibrium dialysis, respectively, in 35
clinical samples.
Figure 4 Free serum cortisol concentrations found in 35
clinical samples by calculation from total serum cortisol and
CBG concentrations, equilibrium dialysis (A) and ultrafiltra-
tion (B), respectively.
substantially higher proportion was found in samples
with CRP concentrations above 5.0 mg/L (20.1% and
23.8%, for ultrafiltration and equilibrium dialysis,
respectively).
Obviously, calculation of free serum cortisol from
the concentrations of total cortisol, CBG, and albumin,
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 18.11.13 10:52
Vogeser et al.: Free serum cortisol measurement 525
Article in press - uncorrected proof
respectively, according to Coolens et al. (14) and Ho
et al. (12), seems to underestimate actual free serum
cortisol concentrations, particularly in patients in a
pronounced acute phase response. In respective sam-
ples from critically ill patients, not only the concentra-
tions but also the binding characteristics of CBG can
be assumed to be substantially altered compared to
normal conditions (7, 15). Therefore, direct measure-
ment of free serum cortisol applying ultrafiltration or
equilibrium dialysis seems to be more accurate in
characterizing individual adrenocortical function in
critical illness.
According to our validation data, both equilibrium
dialysis- and ultrafiltration-based direct measurement
of free serum cortisol can be recommended for fur-
ther research on adrenocortical function in critical ill-
ness. Since free serum cortisol results can be
obtained within a few hours using ultrafiltration and
automated cortisol measurement, this approach is
potentially applicable also in a routine laboratory set-
ting. However, issues of technical standardization as
well as internal and external quality control for meas-
uring free serum cortisol first have to be addressed
very carefully.
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